TGFB1 and breast carcinoma: Bagati A et al. confirmed that breast cancer could escape CD8+ T-cell attack through the integrin αvβ6-TGFβ-SOX4 pathway, which significantly decreases tumor sensitivity to CD8+ T cells [25].